CNTA
Price
$22.20
Change
-$0.20 (-0.89%)
Updated
Jan 16 closing price
Capitalization
3.28B
66 days until earnings call
Intraday BUY SELL Signals
IMMX
Price
$4.70
Change
-$0.01 (-0.21%)
Updated
Jan 16 closing price
Capitalization
248.89M
37 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CNTA vs IMMX

Header iconCNTA vs IMMX Comparison
Open Charts CNTA vs IMMXBanner chart's image
Centessa Pharmaceuticals
Price$22.20
Change-$0.20 (-0.89%)
Volume$1.68M
Capitalization3.28B
Immix Biopharma
Price$4.70
Change-$0.01 (-0.21%)
Volume$719.68K
Capitalization248.89M
CNTA vs IMMX Comparison Chart in %
CNTA
Daily Signal:
Gain/Loss:
IMMX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CNTA vs. IMMX commentary
Jan 19, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTA is a Hold and IMMX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 19, 2026
Stock price -- (CNTA: $22.20 vs. IMMX: $4.70)
Brand notoriety: CNTA and IMMX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTA: 102% vs. IMMX: 64%
Market capitalization -- CNTA: $3.28B vs. IMMX: $248.89M
CNTA [@Biotechnology] is valued at $3.28B. IMMX’s [@Biotechnology] market capitalization is $248.89M. The market cap for tickers in the [@Biotechnology] industry ranges from $111.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTA’s FA Score shows that 0 FA rating(s) are green whileIMMX’s FA Score has 0 green FA rating(s).

  • CNTA’s FA Score: 0 green, 5 red.
  • IMMX’s FA Score: 0 green, 5 red.
According to our system of comparison, CNTA is a better buy in the long-term than IMMX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTA’s TA Score shows that 3 TA indicator(s) are bullish while IMMX’s TA Score has 4 bullish TA indicator(s).

  • CNTA’s TA Score: 3 bullish, 5 bearish.
  • IMMX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both CNTA and IMMX are a bad buy in the short-term.

Price Growth

CNTA (@Biotechnology) experienced а -0.98% price change this week, while IMMX (@Biotechnology) price change was -3.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was +4.14%, and the average quarterly price growth was +42.40%.

Reported Earning Dates

CNTA is expected to report earnings on Mar 26, 2026.

IMMX is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Biotechnology (+1.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CNTA($3.28B) has a higher market cap than IMMX($249M). IMMX YTD gains are higher at: -10.134 vs. CNTA (-11.236). IMMX has higher annual earnings (EBITDA): -23.74M vs. CNTA (-227.27M). CNTA has more cash in the bank: 246M vs. IMMX (15.9M). IMMX has less debt than CNTA: IMMX (1.11M) vs CNTA (118M). CNTA has higher revenues than IMMX: CNTA (15M) vs IMMX (0).
CNTAIMMXCNTA / IMMX
Capitalization3.28B249M1,318%
EBITDA-227.27M-23.74M958%
Gain YTD-11.236-10.134111%
P/E RatioN/AN/A-
Revenue15M0-
Total Cash246M15.9M1,547%
Total Debt118M1.11M10,669%
TECHNICAL ANALYSIS
Technical Analysis
CNTAIMMX
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
Bearish Trend 13 days ago
83%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CNTA
Daily Signal:
Gain/Loss:
IMMX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FACSX49.890.02
+0.04%
Nuveen Mid Cap Value Opportunities C
CGOAX32.84-0.01
-0.03%
Columbia Small Cap Growth A
KLGNX52.77-0.02
-0.04%
NYLI WMC Growth Investor Class
SQCBX14.71-0.02
-0.14%
X-Square Balanced Fund, LLC C
HACAX115.92-0.23
-0.20%
Harbor Capital Appreciation Instl

CNTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTA has been loosely correlated with CLDX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTA jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTA
1D Price
Change %
CNTA100%
-0.89%
CLDX - CNTA
44%
Loosely correlated
-0.16%
DNTH - CNTA
42%
Loosely correlated
+0.23%
VRDN - CNTA
41%
Loosely correlated
+0.70%
CGON - CNTA
40%
Loosely correlated
+3.13%
VCYT - CNTA
37%
Loosely correlated
+1.39%
More

IMMX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMMX has been loosely correlated with CMMB. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if IMMX jumps, then CMMB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMX
1D Price
Change %
IMMX100%
-0.21%
CMMB - IMMX
35%
Loosely correlated
-2.35%
ARQT - IMMX
34%
Loosely correlated
-1.93%
IMTX - IMMX
34%
Loosely correlated
-0.91%
OCUL - IMMX
34%
Loosely correlated
-0.09%
IRD - IMMX
33%
Loosely correlated
+0.96%
More